Brown & Brown arrives at Monday's Q2 earnings report having rallied 17% in a month — yet with short sellers building positions at the fastest pace in weeks, creating a genuine standoff heading into the print.
Short interest has risen sharply. Shares sold short jumped 21% over the past month and nearly 8% in the past week alone, lifting the SI percentage of free float to 5.8%. That is a meaningful and accelerating bet against a stock that has moved decisively higher. Despite the build, the lending market remains loose — availability runs at roughly 389% of current short interest, meaning there is abundant supply for new borrowers, and the cost to borrow is negligible at 0.54%. The short score has also nudged higher, from 51 at the start of July to 55.4 now, consistent with the uptick in positioning. Options traders, by contrast, are not especially defensive — the put/call ratio of 0.32 sits less than one standard deviation above its 20-day average, well below the year's high of 0.83, suggesting the options market is not pricing imminent stress.
The analyst landscape since the prior ORTEX article has grown slightly more nuanced. JP Morgan trimmed its target from $81 to $78 this week while holding Neutral — a modest signal of caution after the run. Wells Fargo also cut marginally, to $68, while Mizuho moved the other way, raising to $81. The Morgan Stanley Underweight at $55, now sitting roughly 21% below the current price of $69.44, remains the outlier bearish anchor. The mean consensus target has drifted up to $74.38, implying only about 7% upside from here — a tight band for a stock that has already run so hard. Bulls point to 5–10% pricing gains in casualty and commercial auto and Specialty Distribution outpacing Retail, while bears flag the continuing collapse in commercial property premiums — down 39% in Q4 — and the drag from lower investment income as interest rates ease. The 12-month forward earnings growth score ranks in the 85th percentile, but near-term EPS momentum scores are weak, sitting in the 20th percentile over 30 days.
Historical reactions add one more layer of context. The prior two quarterly prints — in late April — produced a first-day drop of around 4–7%, followed by further five-day losses of 12–13%. The May event was the exception, nearly flat on day one before a modest five-day pullback of roughly 5%. The pattern of post-earnings weakness is notable given that BRO is now back to price levels that preceded those drops.
Monday's print will test whether the organic growth trajectory and specialty segment momentum can justify a valuation — PE near 14x, EV/EBITDA near 11.5x — that has re-rated sharply higher even as the Street's most bearish voice doubles down and short sellers continue to accumulate.
See the live data behind this article on ORTEX.
Open BRO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
